Open AccessP1559: DISC‐0974, A FIRST‐IN‐HUMAN ANTI‐HEMOJUVELIN MONOCLONAL ANTIBODY, REDUCES SERUM HEPCIDIN LEVELS AND MOBILIZES IRON IN HEALTHY PARTICIPANTS
Author(s) -
Novikov N.,
Yang H.,
Nguyen S.,
Buch A.,
Tuller S.,
Andruk M.,
Chan K.,
Wu M.,
Rodriguez R.,
Panwar R.,
Howell H.,
MacDonald B.,
Savage W.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849092.28359.1f
Subject(s) - hepcidin , tolerability , medicine , ferroportin , ferritin , transferrin saturation , pharmacodynamics , anemia , total iron binding capacity , placebo , serum iron , pharmacokinetics , immunology , gastroenterology , pharmacology , endocrinology , iron deficiency , adverse effect , pathology , alternative medicine